These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. CSF monoamine metabolites and MRI brain volumes in alcohol dependence. Agartz I, Shoaf S, Rawlings RR, Momenan R, Hommer DW. Psychiatry Res; 2003 Jan 20; 122(1):21-35. PubMed ID: 12589880 [Abstract] [Full Text] [Related]
43. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S. Biol Psychiatry; 1983 Oct 20; 18(10):1141-52. PubMed ID: 6197099 [Abstract] [Full Text] [Related]
48. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome]. Takano K, Ishiguro T. Seishin Shinkeigaku Zasshi; 1993 Oct 20; 95(1):1-29. PubMed ID: 7685527 [Abstract] [Full Text] [Related]
58. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Wall SC, Gu H, Rudnick G. Mol Pharmacol; 1995 Mar 20; 47(3):544-50. PubMed ID: 7700252 [Abstract] [Full Text] [Related]
59. Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients. Sedvall GC, Wode-Helgodt B. Arch Gen Psychiatry; 1980 Oct 20; 37(10):1113-6. PubMed ID: 6158928 [Abstract] [Full Text] [Related]
60. Effect of propranolol on monoamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia. Scheinin M, van Kammen DP, Ninan PT, Linnoila M. Clin Pharmacol Ther; 1984 Jul 20; 36(1):33-9. PubMed ID: 6203678 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]